Achieve Life Sciences ACHV Granted (in shares)
Granted (in shares) at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.
The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's granted (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Achieve Life Sciences's granted (in shares)?
- Achieve Life Sciences (ACHV) reported granted (in shares) of $4.36 in Q1 2026.
- How has Achieve Life Sciences's granted (in shares) changed year-over-year?
- Achieve Life Sciences's granted (in shares) increased by 32.1% year-over-year, from $3.30 to $4.36.
- What does granted (in shares) mean?
- The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.